Browsing by Author "Fanlo-Maresma, Marta"
Now showing items 1-5 of 5
-
Asymptomatic carotid atherosclerosis cardiovascular risk factors and common hypertriglyceridemia genetic variants in patients with systemic erythematosus lupus
Fanlo-Maresma, Marta; Candás-Estébanez, Beatriz; Esteve-Luque, Virginia; Padró-Miquel, Ariadna; Escrihuela-Vidal, Francesc; Carratini-Moraes, Monica; Corbella, Emili; Corbella Virós, Xavier; Pintó, Xavier (Journal of Clinical Medicine, 2021)SLE is associated with increased cardiovascular risk. The objective of this study was to determine the prevalence of asymptomatic carotid atherosclerosis to analyze its relationship with dyslipidemia ... -
Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness
Rubio-Rivas, Manuel; Ronda, Mar; Padullés, Ariadna; Mitjavila, Francesca; Riera-Mestre, Antoni; García-Forero, Carlos; Iriarte, Adriana; Mora-Luján, José María; Padullés, Núria; Gonzalez, Monica; Solanich, Xavier; Gasa, Merce; Suarez-Cuartin, Guillermo; Sabater-Riera, Joan; Perez-Fernandez, Xose L.; Santacana, Eugenia; Leiva, Elisabet; Ariza-Sole, Albert; Dallaglio, Paolo D.; Quero, Maria; Soriano, Antonio; Pasqualetto, Alberto; Koo, Maylin; Esteve-Luque, Virginia; Antolí, Arnau; Moreno-Gónzalez, Rafael; Yun, Sergi; Cerdà, Pau; Llaberia, Mariona; Formiga, Francesc; Fanlo-Maresma, Marta; Montero, Abelardo; Chivite, David; Capdevila, Olga; Bolao, Ferran; Pintó, Xavier; Llop, Josep; Sabate, Antoni; Guardiola, Jordi; Cruzado, Josep M.; Comin-Colet, Josep; Santos, Salud; Jodar, Ramon; Corbella Virós, Xavier (Elsevier, 2020-12)Objectives: To assess the characteristics and risk factors for mortality in patients with severe coronavirus disease-2019 (COVID-19) treated with tocilizumab (TCZ), alone or in combination with ... -
Implication between genetic variants from APOA5 and ZPR1 and NAFLD severity in patients with hypertriglyceridemia
Esteve-Luque, Virginia; Padró-Miquel, Ariadna; Fanlo-Maresma, Marta; Corbella, Emili; Corbella Virós, Xavier; Pintó, Xavier; Candás-Estébanez, Beatriz (Nutrients, 2021)Background: Lipid metabolism disorders, especially hypertriglyceridemia (HTG), are risk factors for non-alcoholic fatty liver disease (NAFLD). However, the association between genetic factors related ... -
Methylprednisolone pulses plus tacrolimus in addition to standard of care vs. standard of care alone in patients with severe COVID-19. A randomized controlled trial
Solanich, Xavier; Antolí, Arnau; Rocamora-Blanch, Gemma; Padullés, Núria; Fanlo-Maresma, Marta; Iriarte, Adriana; Mitjavila, Francesca; Capdevila, Olga; Riera-Mestre, Antoni; Bas, Jordi; Vicens-Zygmunt, Vanesa; Niubó, Jordi; Calvo, Nahum; Bolivar, Santiago; Rigo-Bonnin, Raúl; Mensa-Vilaró, Anna; Arregui, Laura; Tebé, Cristian; Videla, Sebastià; Hereu, Pilar; Corbella Virós, Xavier (Frontiers in Medicine, 2021)Introduction: Severe lung injury is triggered by both the SARS-CoV-2 infection and the subsequent host-immune response in some COVID-19 patients. Methods: We conducted a randomized, single-center, ... -
Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: the TACROVID trial protocol
Solanich, Xavier; Antolí, Arnau; Padullés, Núria; Fanlo-Maresma, Marta; Iriarte, Adriana; Mitjavila, Francesca; Capdevila, Olga; Molina, M.; Sabater-Riera, Joan; Bas, Jordi; Mensa-Vilaró, Anna; Niubó, Jordi; Calvo, Nahum; Bolivar, Santiago; Rigo-Bonnin, Raúl; Arregui, Laura; Tebé, Cristian; Hereu, Pilar; Videla, S.; Corbella Virós, Xavier (Contemporary Clinical Trials Communications, 2021-03)Introduction: Some COVID-19 patients evolve to severe lung injury and systemic hyperinflammatory syndrome triggered by both the coronavirus infection and the subsequent host-immune response. Accordingly, ...